Clindamycin with primaquine vs. trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: A multicenter, double-blind, randomized trial (CTN 004)

Clinical Infectious Diseases

Volumn 27, Issue 3, 1998, Pages 524-530

  Toma, Emil ^a   Thorne, Anona ^b   Singer, Joel ^b   Raboud, Janet ^b   Lemieux, Claude ^b   Trottier, Sylvie ^b   Bergeron, Michel G ^b   Tsoukas, Chris ^b   Falutz, Julian ^b   Lalonde, Richard ^b   Gaudreau, Christiane ^b   Therrien, Rachel ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; PRIMAQUINE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG USE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; STEROID EXCRETION;

EID: 17344372336     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514696     Document Type: Article

References (23)

1. Montaner JSG, Le T, Hogg R, et al. The changing spectrum of AIDS index diseases in Canada. AIDS 1994;8:693-6.
2. Katz MH, Hessol NA, Buchbinder SP, Hirozawa A, O'Malley P, Holmberg SD. Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J Infect Dis 1994;170:198-202.
3. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med 1993;329:1922-6.
4. Sepkowitz KA, Armstrong D. Treatment of opportunistic infections in AIDS. Lancet 1995;346:588-9.
5. Hughes W, Leoung G, Kramer F, et al. Comparison of atovaquone (566 C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N Engl J Med 1993;328:1521-7.
6. Medina I, Mills J, Leoung G, et al. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med 1990;323:776-82.
7. Sattler FR, Frame P, Davis R, et al. Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled, multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031. J Infect Dis 1994;170:165-72.
8. Feinberg J, McDermott C, Nuter J. Trimetrexate (TMTX) salvage therapy for PCP in AIDS patients with limited therapeutic options [abstract no PoB 3297]. In: Program and abstracts of the 8th International Conference on AIDS (Amsterdam). Vol 2. Amsterdam: CONGREX Holland BV, 1992:B136.
9. Dohn MN, Weinberg WG, Torres RA, et al. Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Ann Intern Med 1994;121:171-80.
10. Queener SF, Bartlett MS, Richardson JD, Durkin MM, Jay MA, Smith JW. Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother 1988;32:807-13.
11. Toma E, Fournier S, Poisson M, Morisset R, Phaneuf D, Vega C. Clindamycin with primaquine for Pneumocystis carinii pneumonia. Lancet 1989;1:1046-8.
12. Black JR, Feinberg J, Murphy RL, Pass RJ, Carey J, Sattler FR. Clindamycin and primaquine as primary treatment for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS. Eur J Clin Microbiol Infect Dis 1991;10:204-7.
13. Ruf B, Rohde I, Pohle HD. Efficacy of clindamycin/primaquine versus trimethoprim/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia. Eur J Clin Microbiol Infect Dis 1991;10:207-10.
14. Toma E. Clindamycin/primaquine for treatment of Pneumocystis carinii pneumonia in AIDS. Eur J Clin Microbiol Infect Dis 1991;10:210-3.
15. Noskin GA, Murphy RL, Black JR, Phair JP. Salvage therapy with clindamycin/primaquine for Pneumocystis carinii pneumonia. Clin Infect Dis 1992;14:183-8.
16. Black JR, Feinberg J, Murphy RL, et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystic carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044. Clin Infect Dis 1994;18:905-13.
17. Toma E, Fournier S, Dumont M, Bolduc P, Deschamps H. Clindamycin/primaquine vs. trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind, pilot trial. Clin Infect Dis 1993;17:178-84.
18. Safrin S, Finkelstein DM, Feinberg J, et al. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. Ann Intern Med 1996;124:792-802.
19. The National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990;323:1500-4.
20. Montaner JSG, Lawson LM, Levitt N, Beizberg A, Schechter MT, Ruedy J. Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990;113:14-20.
21. Walmsley S, Levinton C, Brunton J, et al. A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome. J Acquir Immune Defic Syndr Human Retroviral 1995;8:348-57.
22. Nichols LC, Black J, Sattler F, Feinberg J. A quantitative scoring system for evaluating the response to therapy of Pneumocystis carinii pneumonia (PCP) [abstract no T.B.P. 22]. In: Program and abstracts of the 5th International Conference on AIDS (Montreal). Ottawa: International Development Research Centre, 1989.
23. Vanhems P, Toma E. Evaluation of a prognostic score for Pneumocystis carinii pneumonia in HIV-infected patients. Chest 1995;107:107-12.